SCHEMBL2929698

SCHEMBL2929698

CCOC(=O)[C@@](C)(NC(=O)OC(C)(C)C)c1ccccc1P(=O)(OCC)OCC

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
PTPRB P23467 1/20 0.38
ALDH1A1 P00352 4/20 0.38
RECQL P46063 1/20 0.38
ATM Q13315 2/20 0.37
SYK P43405 1/20 0.37
KDM4E B2RXH2 2/20 0.36
MMP8 P22894 1/20 0.35
LMNA P02545 2/20 0.33
AKT1 P31749 2/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
PIN1 Q13526 1/20 0.33
MAPT P10636 1/20 0.33
POLB P06746 1/20 0.33
NLRP3 Q96P20 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2927231 0.80 KMT2A (0.42) KMT2AMEN1PTPRBALDH1A1RECQL
SCHEMBL1111262 0.79 PTPRB (0.39) KMT2AMEN1PTPRBALDH1A1RECQL
SCHEMBL2923423 0.79 MEN1 (0.40) KMT2AMEN1ALDH1A1RECQLATM
SCHEMBL2923426 0.74 CTSK (0.42) KMT2AMEN1ALDH1A1ATMSYK
SCHEMBL2929227 0.74 CTSK (0.42) KMT2AMEN1ALDH1A1ATMSYK
SCHEMBL2490507 0.69 ABCB11 (0.49) KMT2APTPRBALDH1A1RECQLKDM4E
SCHEMBL7233451 0.69 PTPRB (0.45) PTPRBALDH1A1RECQLSYKKDM4E
SCHEMBL2925457 0.69 PTPRB (0.42) KMT2AMEN1PTPRBALDH1A1RECQL
SCHEMBL2927031 0.69 CTSK (0.45) KMT2AMEN1ATMSYK
SCHEMBL2923417 0.69 CTSK (0.45) KMT2AMEN1ATMSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225253-A1 PHOSPHONIC ACID DERIVATES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2010-09-08 EP disclosed
WO-2009069100-A1 PHOSPHONIC ACID DERIVATES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-06-04 WO disclosed